1
|
Soh C, Hervault M, Rohl AH, Greenlee JDW, Wessel JR. Precisely-timed outpatient recordings of subcortical local field potentials from wireless streaming-capable deep-brain stimulators: a method and toolbox. J Neurosci Methods 2025; 418:110448. [PMID: 40220907 DOI: 10.1016/j.jneumeth.2025.110448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2024] [Revised: 02/19/2025] [Accepted: 04/09/2025] [Indexed: 04/14/2025]
Abstract
BACKGROUND Investigations of the electrophysiological mechanisms of the human subcortex have relied on recording local field potentials (LFPs) during deep-brain stimulation (DBS) neurosurgery. However, the neurosurgical setting severely restricts the research use of these recordings. Recently developed sensing-capable DBS devices wirelessly stream subcortical LFPs in outpatient settings. These recordings have tremendous potential for research. However, synchronizing them with other behavior or neural recordings is challenging, as the clinical devices do not accept digital timing information. NEW METHOD Switching the DBS device on introduces transient yet consistent artifacts in both the LFP and simultaneous scalp-EEG recordings. We use these artifacts as a reference to align these recordings (N = 20). We tested whether the alignment was precise enough to match a ground truth state (large artifacts produced by transcranial magnetic stimulation, TMS), yielded trial-averaged event-locked LFPs, and phase consistency across trials. We further evaluated the consistency of task-related LFPs across outpatient and perisurgical recordings. RESULTS AND COMPARISON WITH EXISTING METHOD(S) Previous alignment methods were limited because they relied on inconsistent on/offset features of DBS artifacts caused by ongoing stimulation. Moreover, they only provided limited validation. Our highly precise alignment method showed a maximum deviation of only 8 ms - clearly superior to prior techniques. Furthermore, event-related activity patterns were comparable across outpatient and perisurgical LFP recordings. CONCLUSIONS We present a method and a MATLAB toolbox that inserts the most precise digital timing information into wirelessly-streamed DBS-LFP recordings to date. By enabling event-related research with high-temporal precision, this method greatly enhances the utility of these recordings.
Collapse
Affiliation(s)
- Cheol Soh
- Department of Psychological and Brain Sciences, University of Iowa, United States; Cognitive Control Collaborative, University of Iowa, United States.
| | - Mario Hervault
- Department of Psychological and Brain Sciences, University of Iowa, United States; Cognitive Control Collaborative, University of Iowa, United States
| | - Andrea H Rohl
- Department of Neurosurgery, University of Iowa, United States
| | | | - Jan R Wessel
- Department of Psychological and Brain Sciences, University of Iowa, United States; Cognitive Control Collaborative, University of Iowa, United States; Department of Neurology, University of Iowa, United States
| |
Collapse
|
2
|
Luo Z, Peng K, Liang Z, Cai S, Xu C, Li D, Hu Y, Zhou C, Liu Q. Mapping effective connectivity by virtually perturbing a surrogate brain. Nat Methods 2025:10.1038/s41592-025-02654-x. [PMID: 40263586 DOI: 10.1038/s41592-025-02654-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Accepted: 03/03/2025] [Indexed: 04/24/2025]
Abstract
Effective connectivity (EC), which reflects the causal interactions between brain regions, is fundamental to understanding information processing in the brain; however, traditional methods for obtaining EC, which rely on neural responses to stimulation, are often invasive or limited in spatial coverage, making them unsuitable for whole-brain EC mapping in humans. Here, to address this gap, we introduce Neural Perturbational Inference (NPI), a data-driven framework for mapping whole-brain EC. NPI employs an artificial neural network trained to model large-scale neural dynamics, serving as a computational surrogate of the brain. By systematically perturbing all regions in the surrogate brain and analyzing the resulting responses in other regions, NPI maps the directionality, strength and excitatory/inhibitory properties of brain-wide EC. Validation of NPI on generative models with known ground-truth EC demonstrates its superiority over existing methods such as Granger causality and dynamic causal modeling. When applied to resting-state functional magnetic resonance imaging data across diverse datasets, NPI reveals consistent, structurally supported EC patterns. Furthermore, comparisons with cortico-cortical evoked potential data show a strong resemblance between NPI-inferred EC and real stimulation propagation patterns. By transitioning from correlational to causal understandings of brain functionality, NPI marks a stride in decoding the brain's functional architecture and facilitating both neuroscience studies and clinical applications.
Collapse
Affiliation(s)
- Zixiang Luo
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
- Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China
| | - Kaining Peng
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
| | - Zhichao Liang
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
| | - Shengyuan Cai
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
| | - Chenyu Xu
- Department of Electrical and Computer Engineering, Iowa State University, Ames, IA, USA
| | - Dan Li
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
| | - Yu Hu
- Department of Mathematics, The Hong Kong University of Science and Technology, Hong Kong SAR, China
- Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR, China
| | - Changsong Zhou
- Department of Physics, Centre for Nonlinear Studies, Hong Kong Baptist University, Hong Kong SAR, China
| | - Quanying Liu
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China.
| |
Collapse
|
3
|
Binns TS, Köhler RM, Vanhoecke J, Chikermane M, Gerster M, Merk T, Pellegrini F, Busch JL, Habets JGV, Cavallo A, Beyer JC, Al-Fatly B, Li N, Horn A, Krause P, Faust K, Schneider GH, Haufe S, Kühn AA, Neumann WJ. Shared pathway-specific network mechanisms of dopamine and deep brain stimulation for the treatment of Parkinson's disease. Nat Commun 2025; 16:3587. [PMID: 40234441 PMCID: PMC12000430 DOI: 10.1038/s41467-025-58825-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 03/28/2025] [Indexed: 04/17/2025] Open
Abstract
Deep brain stimulation is a brain circuit intervention that can modulate distinct neural pathways for the alleviation of neurological symptoms in patients with brain disorders. In Parkinson's disease, subthalamic deep brain stimulation clinically mimics the effect of dopaminergic drug treatment, but the shared pathway mechanisms on cortex - basal ganglia networks are unknown. To address this critical knowledge gap, we combined fully invasive neural multisite recordings in patients undergoing deep brain stimulation surgery with normative MRI-based whole-brain connectomics. Our findings demonstrate that dopamine and stimulation exert distinct mesoscale effects through modulation of local neural population activity. In contrast, at the macroscale, stimulation mimics dopamine in its suppression of excessive interregional network synchrony associated with indirect and hyperdirect cortex - basal ganglia pathways. Our results provide a better understanding of the circuit mechanisms of dopamine and deep brain stimulation, laying the foundation for advanced closed-loop neurostimulation therapies.
Collapse
Affiliation(s)
- Thomas S Binns
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
| | - Richard M Köhler
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Jojo Vanhoecke
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Meera Chikermane
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Moritz Gerster
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
- Research Group Neural Interactions and Dynamics, Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
- Neurophysics Group, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Timon Merk
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Franziska Pellegrini
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
- Berlin Center for Advanced Neuroimaging, Bernstein Center for Computational Neuroscience, Berlin, Germany
| | - Johannes L Busch
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Jeroen G V Habets
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Alessia Cavallo
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
| | - Jean-Christin Beyer
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Bassam Al-Fatly
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Ningfei Li
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Andreas Horn
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Patricia Krause
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Katharina Faust
- Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Gerd-Helge Schneider
- Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Stefan Haufe
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
- Berlin Center for Advanced Neuroimaging, Bernstein Center for Computational Neuroscience, Berlin, Germany
- Technische Universität Berlin, Berlin, Germany
- Physikalisch-Technische Bundesanstalt Braunschweig und Berlin, Berlin, Germany
| | - Andrea A Kühn
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany
- NeuroCure Clinical Research Centre, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Wolf-Julian Neumann
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany.
| |
Collapse
|
4
|
Mehta K, Noecker AM, McIntyre CC. Comparison of structural connectomes for modeling deep brain stimulation pathway activation. Neuroimage 2025; 312:121211. [PMID: 40222498 DOI: 10.1016/j.neuroimage.2025.121211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Revised: 03/20/2025] [Accepted: 04/11/2025] [Indexed: 04/15/2025] Open
Abstract
INTRODUCTION Structural connectivity models of the brain are commonly employed to identify pathways that are directly activated during deep brain stimulation (DBS). However, various connectomes differ in the technical parameters, parcellation schemes, and methodological approaches used in their construction. OBJECTIVE The goal of this study was to compare and quantify variability in DBS pathway activation predictions when using different structural connectomes, while using identical electrode placements and stimulation volumes in the brain. APPROACH We analyzed four example structural connectomes: 1) Horn normative connectome (whole brain), 2) Yeh population-averaged tract-to-region pathway atlas (whole brain), 3) Petersen histology-based pathway atlas (subthalamic focused), and 4) Majtanik histology-based pathway atlas (anterior thalamus focused). DBS simulations were performed with each connectome, at four generalized locations for DBS electrode placement: 1) subthalamic nucleus, 2) anterior nucleus of thalamus, 3) ventral capsule, and 4) ventral intermediate nucleus of thalamus. RESULTS The choice of connectome used in the simulations resulted in notably distinct pathway activation predictions, and quantitative analysis indicated little congruence in the predicted patterns of brain network connectivity. The Horn and Yeh tractography-based connectomes provided estimates of DBS connectivity for any stimulation location in the brain, but have limitations in their anatomical validity. The Petersen and Majtanik histology-based connectomes are more anatomically realistic, but are only applicable to specific DBS targets because of their limited representation of pathways. SIGNIFICANCE The widely varying and inconsistent inferences of DBS network connectivity raises substantial concern regarding the general reliability of connectomic DBS studies, especially those that lack anatomical and/or electrophysiological validation in their analyses.
Collapse
Affiliation(s)
- Ketan Mehta
- Department of Biomedical Engineering, Duke University, Durham, NC, United States
| | - Angela M Noecker
- Department of Biomedical Engineering, Duke University, Durham, NC, United States
| | - Cameron C McIntyre
- Department of Biomedical Engineering, Duke University, Durham, NC, United States; Department of Neurosurgery, Duke University, Durham, NC, United States.
| |
Collapse
|
5
|
Vissani M, Bush A, Lipski WJ, Bullock L, Fischer P, Neudorfer C, Holt LL, Fiez JA, Turner RS, Mark Richardson R. Spike-phase coupling of subthalamic neurons to posterior perisylvian cortex predicts speech sound accuracy. Nat Commun 2025; 16:3357. [PMID: 40204804 PMCID: PMC11982203 DOI: 10.1038/s41467-025-58781-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2024] [Accepted: 03/28/2025] [Indexed: 04/11/2025] Open
Abstract
Speech provides a rich context for understanding how cortical interactions with the basal ganglia contribute to unique human behaviors, but opportunities for direct human intracranial recordings across cortical-basal ganglia networks are rare. Here we have recorded electrocorticographic signals in the cortex synchronously with single units in the basal ganglia during awake neurosurgeries where participants spoke syllable repetitions. We have discovered that individual subthalamic nucleus (STN) neurons have transient (200 ms) spike-phase coupling (SPC) events with multiple cortical regions. The spike timing of STN neurons is locked to the phase of theta-alpha oscillations in the supramarginal and posterior superior temporal gyrus during speech planning and production. Speech sound errors occur when this STN-cortical interaction is delayed. Our results suggest that timely interactions between the STN and the posterior perisylvian cortex support auditory-motor coordinate transformation or phonological working memory during speech planning. These findings establish a framework for understanding cortical-basal ganglia interaction in other human behaviors, and additionally indicate that firing-rate based models are insufficient for explaining basal ganglia circuit behavior.
Collapse
Affiliation(s)
- Matteo Vissani
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
| | - Alan Bush
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Witold J Lipski
- Department of Neurobiology, Systems Neuroscience Center and Center for Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Latané Bullock
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
- Program in Speech and Hearing Bioscience and Technology, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA
| | - Petra Fischer
- School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK
| | - Clemens Neudorfer
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Lori L Holt
- Department of Psychology, The University of Texas at Austin, Austin, TX, USA
| | - Julie A Fiez
- Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA
| | - Robert S Turner
- Department of Neurobiology, Systems Neuroscience Center and Center for Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - R Mark Richardson
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
6
|
Meyer GM, Sahin IA, Hollunder B, Butenko K, Rajamani N, Neudorfer C, Hart LA, Petry‐Schmelzer JN, Dafsari HS, Barbe MT, Visser‐Vandewalle V, Mosley PE, Horn A. Subthalamic Deep Brain Stimulation: Mapping Non-Motor Outcomes to Structural Connections. Hum Brain Mapp 2025; 46:e70207. [PMID: 40193128 PMCID: PMC11974458 DOI: 10.1002/hbm.70207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 03/02/2025] [Accepted: 03/23/2025] [Indexed: 04/10/2025] Open
Abstract
In Parkinson's Disease (PD), deep brain stimulation of the subthalamic nucleus (STN-DBS) reliably improves motor symptoms, and the circuits mediating these effects have largely been identified. However, non-motor outcomes are more variable, and it remains unclear which specific brain circuits need to be modulated or avoided to improve them. Since numerous non-motor symptoms potentially respond to DBS, it is challenging to independently identify the circuits mediating each one of them. Data compression algorithms such as principal component analysis (PCA) may provide a powerful alternative. This study aimed at providing a proof of concept for this approach by mapping changes along extensive score batteries to a few anatomical fiber bundles and, in turn, estimating changes in individual scores based on stimulation of these tracts. Retrospective data from 56 patients with PD and bilateral STN-DBS was included. The patients had undergone comprehensive clinical assessments covering changes in appetitive behaviors, mood, anxiety, impulsivity, cognition, and empathy. PCA was implemented to identify the main dimensions of neuropsychiatric and neuropsychological outcomes. Using DBS fiber filtering, we identified the structural connections whose stimulation was associated with change along these dimensions. Then, estimates of individual symptom outcomes were derived based on the stimulation of these connections by inverting the PCA. Finally, changes along a specific non-motor score were estimated in an independent validation dataset (N = 68) using the tract model. Four principal components were retained, which could be interpreted to reflect (i) general non-motor improvement; (ii) improvement of mood and cognition and worsening of trait impulsivity; (iii) improvement of cognition; and (iv) improvement of empathy and worsening of impulsive-compulsive behaviors. Each component was associated with the stimulation of spatially segregated fiber bundles connecting regions of the frontal cortex with the subthalamic nucleus. The extent of stimulation of these tracts was able to explain significant amounts of variance in outcomes for individual symptoms in the original cohort (circular analysis), as well as in the rank of depression outcomes in the independent validation cohort. Our approach represents an innovative concept for mapping changes along extensive score batteries to a few anatomical fiber bundles and could pave the way toward personalized deep brain stimulation.
Collapse
Affiliation(s)
- Garance M. Meyer
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Ilkem Aysu Sahin
- Movement Disorders and Neuromodulation Unit, Department of NeurologyCharité – Universitätsmedizin BerlinBerlinGermany
- Einstein Center for Neurosciences Berlin, Charité – Universitätsmedizin BerlinBerlinGermany
- Berlin School of Mind and Brain, Humboldt‐Universität Zu BerlinBerlinGermany
| | - Barbara Hollunder
- Movement Disorders and Neuromodulation Unit, Department of NeurologyCharité – Universitätsmedizin BerlinBerlinGermany
- Einstein Center for Neurosciences Berlin, Charité – Universitätsmedizin BerlinBerlinGermany
- Berlin School of Mind and Brain, Humboldt‐Universität Zu BerlinBerlinGermany
| | - Konstantin Butenko
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Nanditha Rajamani
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
- Movement Disorders and Neuromodulation Unit, Department of NeurologyCharité – Universitätsmedizin BerlinBerlinGermany
- Einstein Center for Neurosciences Berlin, Charité – Universitätsmedizin BerlinBerlinGermany
- Berlin School of Mind and Brain, Humboldt‐Universität Zu BerlinBerlinGermany
| | - Clemens Neudorfer
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
- Department of NeurosurgeryMassachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Lauren A. Hart
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | | | - Haidar S. Dafsari
- Department of Neurology, Faculty of Medicine and University HospitalUniversity of CologneCologneGermany
| | - Michael T. Barbe
- Department of Neurology, Faculty of Medicine and University HospitalUniversity of CologneCologneGermany
| | - Veerle Visser‐Vandewalle
- Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University HospitalUniversity of CologneCologneGermany
| | - Philip E. Mosley
- Clinical Brain Networks Group, QIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
- Neurosciences Queensland, St Andrew's War Memorial HospitalBrisbaneQueenslandAustralia
- Queensland Brain Institute, University of QueenslandBrisbaneQueenslandAustralia
- Australian eHealth Research Centre, CSIRO Health and BiosecurityBrisbaneQueenslandAustralia
| | - Andreas Horn
- Center for Brain Circuit Therapeutics, Department of NeurologyBrigham & Women's Hospital, Harvard Medical SchoolBostonMassachusettsUSA
- Movement Disorders and Neuromodulation Unit, Department of NeurologyCharité – Universitätsmedizin BerlinBerlinGermany
- Einstein Center for Neurosciences Berlin, Charité – Universitätsmedizin BerlinBerlinGermany
- Department of NeurosurgeryMassachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| |
Collapse
|
7
|
Wang S, Liu Y, Peng LC, Duan W, Shu Y, Tian Y. A Self-Supporting Flexible Electrode for Tracking and Reversible Quantification of Mg 2+ and Ca 2+ in the Brains of Freely Behaving Animal. Angew Chem Int Ed Engl 2025; 64:e202422602. [PMID: 39789605 DOI: 10.1002/anie.202422602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2024] [Revised: 01/07/2025] [Accepted: 01/08/2025] [Indexed: 01/12/2025]
Abstract
Monitoring dynamic neurochemical signals in the brain of free-moving animals remains great challenging in biocompatibility and direct implantation capability of current electrodes. Here we created a self-supporting polymer-based flexible microelectrode (rGPF) with sufficient bending stiffness for direct brain implantation without extra devices, but demonstrating low Young's modulus with remarkable biocompatibility and minimal position shifts. Meanwhile, screening by density functional theory (DFT) calculation, we designed and synthesized specific ligands targeting Mg2+ and Ca2+, and constructed Mg-E and Ca-E sensors with high selectivity, good reversibility, and fast response time, successfully monitoring Mg2+ and Ca2+ in vivo up to 90 days. Using this powerful tool, we discovered for the first time that, during the 4-aminopyridine-induced seizure in the live brain, extracellular Mg2+ inhibited Ca2+ influx. Moreover, the timing of initial changes in Mg2+ and Ca2+ levels during seizures aligned with neural pathways, which had not been previously reported.
Collapse
Affiliation(s)
- Shidi Wang
- School of Chemistry and Molecular Engineering, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China
| | - Yuandong Liu
- School of Chemistry and Molecular Engineering, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China
| | - Lin-Chun Peng
- School of Chemistry and Molecular Engineering, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China
| | - Wei Duan
- Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China
| | - Yousheng Shu
- Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China
| | - Yang Tian
- School of Chemistry and Molecular Engineering, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China
| |
Collapse
|
8
|
Horn A, Li N, Meyer GM, Gadot R, Provenza NR, Sheth SA. Deep Brain Stimulation response circuits in Obsessive Compulsive Disorder. Biol Psychiatry 2025:S0006-3223(25)01096-0. [PMID: 40120789 DOI: 10.1016/j.biopsych.2025.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2024] [Revised: 03/05/2025] [Accepted: 03/11/2025] [Indexed: 03/25/2025]
Abstract
In the field of deep brain stimulation (DBS), two major themes are currently making significant progress. First, the framework of connectomic DBS, in which circuits that are associated with improvements of specific symptoms are described and targeted to improve and potentially personalize treatment. Second, the concept of brain sensing and adaptive DBS, which aims at identifying neural biomarkers that may guide stimulation in a closed-loop fashion. In DBS for Obsessive Compulsive Disorder (OCD), substantial progress has been made on both ends, over the last five years. Together, results begin to draw a picture of exactly which circuit is associated with treatment response, and how it may be affected by dysfunctional brain activity that may be attenuated using DBS. In turn, this knowledge, if further refined and validated, will define where, when, and how to stimulate which patients with OCD. We review the key studies from recent years with the aim to aggregate and condense findings along both spatial and temporal domains. The result is a concept that anatomically defines a circuit that is likely dysfunctional in patients with typical OCD phenotypes, and which may be adaptively targeted using DBS to maximally improve symptoms.
Collapse
Affiliation(s)
- Andreas Horn
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Boston MA 02115, USA; MGH Neurosurgery & Center for Neurotechnology and Neurorecovery (CNTR) at MGH Neurology Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
| | - Ningfei Li
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology, 10117 Berlin, Germany
| | - Garance M Meyer
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Boston MA 02115, USA
| | - Ron Gadot
- Department of Neurosurgery, Brigham & Women's Hospital, Harvard Medical School, Boston MA 02115, USA
| | - Nicole R Provenza
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA; Department of Electrical & Computer Engineering, Rice University, Houston, TX, USA
| | - Sameer A Sheth
- Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA; Department of Electrical & Computer Engineering, Rice University, Houston, TX, USA; Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
9
|
Lee AM, Kist A, Alvarez J, Sellers KK, Khambhati AN, Sugrue LP, Reid LB, Kadlec K, Fan JM, Allawala AB, Racine CA, Norbu T, Astudillo D, Tremblay-McGaw AG, Becker N, Alhourani A, Starr PA, Chang EF, Krystal AD. Invasive Brain Mapping Identifies Personalized Therapeutic Neuromodulation Targets for Obsessive-Compulsive Disorder. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2025:2025.03.14.25323348. [PMID: 40166548 PMCID: PMC11957075 DOI: 10.1101/2025.03.14.25323348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/02/2025]
Abstract
Deep brain stimulation has been used to treat severe, refractory obsessive-compulsive disorder (OCD) with variable outcomes across multiple anatomical targets. To overcome these limitations, we developed an invasive brain mapping paradigm in which electrodes were implanted across the OCD cortico-striato-thalamo-cortical circuit in a single individual. We then performed extensive stimulation mapping during a multi-day inpatient stay to identify personalized therapeutic targets and characterize their downstream circuit effects. We found two targets within the right ventral capsule (VC) that acutely reduced OCD symptoms. Prolonged VC stimulation suppressed high frequency activity within the structurally and functionally connected orbitofrontal cortex, which encoded the severity of OCD symptoms. These VC sites were implanted for DBS and combined stimulation of these targets led to a rapid therapeutic response. This case provides the first proof-of-concept that invasive brain mapping can be used to guide a novel personalized, multi-site neuromodulation approach to treat refractory OCD.
Collapse
Affiliation(s)
- A Moses Lee
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Audrey Kist
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - John Alvarez
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Kristin K Sellers
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Ankit N Khambhati
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Leo P Sugrue
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Radiology and Biomedical Imaging, University of California, San Francisco
| | - Lee B Reid
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
- Department of Radiology and Biomedical Imaging, University of California, San Francisco
| | - Kelly Kadlec
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Joline M Fan
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurology, University of California, San Francisco
| | - Anusha B Allawala
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Caroline A Racine
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Tenzin Norbu
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Dani Astudillo
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Alexandra G Tremblay-McGaw
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Natalie Becker
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Ahmad Alhourani
- Department of Neurological Surgery, University of California, San Francisco
| | - Philip A Starr
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Edward F Chang
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Andrew D Krystal
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| |
Collapse
|
10
|
Dong J, Peschke S, Kirschner A, Palleis C, Mehrkens JH, Scherer M, Kaufmann E, Koeglsperger T. Subjective patient rating as a novel feedback signal for DBS programming in Parkinson's disease. Brain Stimul 2025; 18:770-779. [PMID: 40081467 DOI: 10.1016/j.brs.2025.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2024] [Revised: 02/24/2025] [Accepted: 03/09/2025] [Indexed: 03/16/2025] Open
Abstract
BACKGROUND Deep brain stimulation of the subthalamic nucleus (STN-DBS) effectively alleviates motor fluctuations in Parkinson's disease (PD). Optimal electrode placement and effective programming significantly influence outcomes. From a patient's perspective, DBS should relieve motor symptoms while avoiding side effects. However, there is a lack of programming routines that consider patients' subjective feedback for parameter adjustment. OBJECTIVE This study assessed the usefulness of patients' subjective ratings as feedback for DBS programming. METHODS We analyzed 260 DBS settings from 11 STN-DBS patients, pairing each volume of tissue activated (VTA) with a subjective rating measured by a visual analogue scale (VAS). We performed sweet spot mapping and connectivity analyses, utilizing voxel-wise and nonparametric permutation statistics to identify neuroanatomical regions and connectivity profiles associated with the highest VAS ratings. To validate our findings, we cross-validated the results in an independent test dataset of 6 patients (189 settings) to determine if the sweet spot and connectivity profile could predict the subjective patient perception. RESULTS VTAs with the highest VAS scores were localized to the dorsolateral STN, consistent with published sweet spots derived from clinical data. Connectivity with the supplementary motor area (SMA) and primary motor cortex (M1) was associated with a more positive subjective perception. Connectivity profiles derived from one dataset successfully predicted outcomes in an independent dataset, as validated through leave-one-cohort-out cross-validation. CONCLUSIONS Mapping patients' subjective perceptions using VAS yields conclusive anatomical results that align with objective clinical and imaging measures. VAS-guided programming could provide an additional feedback mechanism for both acute and chronic DBS parameter adjustments.
Collapse
Affiliation(s)
- Jing Dong
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
| | - Sophia Peschke
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
| | - Angelina Kirschner
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
| | - Carla Palleis
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany; Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Jan Hinnerk Mehrkens
- Department of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany
| | - Maximilian Scherer
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
| | - Elisabeth Kaufmann
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
| | - Thomas Koeglsperger
- Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany; Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
| |
Collapse
|
11
|
Gelineau-Morel R, Dlamini N, Bruss J, Cohen AL, Robertson A, Alexopoulos D, Smyser CD, Boes AD. Network Localization of Pediatric Lesion-Induced Dystonia. Ann Neurol 2025. [PMID: 40059836 DOI: 10.1002/ana.27224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 01/23/2025] [Accepted: 02/14/2025] [Indexed: 03/19/2025]
Abstract
OBJECTIVE Dystonia is a movement disorder defined by involuntary muscle contractions leading to abnormal postures or twisting and repetitive movements. Classically dystonia has been thought of as a disorder of the basal ganglia, but newer results in idiopathic dystonia and lesion-induced dystonia in adults point to broader motor network dysfunction spanning the basal ganglia, cerebellum, premotor cortex, sensorimotor, and frontoparietal regions. It is unclear whether a similar network is shared between different etiologies of pediatric lesion-induced dystonia. METHODS Three cohorts of pediatric patients with lesion-induced dystonia were identified. The lesion etiologies included hypoxia, kernicterus, and stroke versus comparison subjects with acquired lesions not associated with dystonia. Multivariate lesion-symptom mapping and lesion network mapping were used to evaluate the anatomy and networks associated with dystonia. RESULTS Multivariate lesion-symptom mapping showed that lesions of the putamen and globus pallidus were associated with dystonia (r = 0.41, p < 0.001). Lesion network mapping using normative connectome data from healthy children demonstrated that these regional findings occurred within a common brain-wide network that involves the basal ganglia, anterior and medial cerebellum, and cortical regions that overlap the cingulo-opercular action-mode and somato-cognitive-action networks. INTERPRETATION We interpret these findings as novel evidence for a unified dystonia brain network that involves the somato-cognitive-action network, which is implicated in the coordination of movement. Elucidation of this network gives insight into the functional origins of dystonia and provides novel targets to investigate for therapeutic intervention. ANN NEUROL 2025.
Collapse
Affiliation(s)
- Rose Gelineau-Morel
- Division of Neurology, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, MO
- School of Medicine, University of Missouri-Kansas City, Kansas City, MO
| | - Nomazulu Dlamini
- Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada
- Faculty of Medicine, University of Toronto, Toronto, Canada
| | - Joel Bruss
- Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA
- Department of Neurology, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA
| | - Alexander L Cohen
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA
| | - Amanda Robertson
- Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada
| | | | - Christopher D Smyser
- Department of Neurology, Washington University, St Louis, MO
- Department of Pediatrics, Washington University, St Louis, MO
- Mallinckrodt Institute of Radiology, Washington University, St Louis, MO
| | - Aaron D Boes
- Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA
- Department of Neurology, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, IA
- Iowa Neuroscience Institute, University of Iowa, Iowa City, IA
| |
Collapse
|
12
|
Santyr B, Boutet A, Ajala A, Germann J, Qiu J, Fasano A, Lozano AM, Kucharczyk W. Emerging Techniques for the Personalization of Deep Brain Stimulation Programming. Can J Neurol Sci 2025:1-13. [PMID: 39963066 DOI: 10.1017/cjn.2025.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/21/2025]
Abstract
The success of deep brain stimulation (DBS) relies on applying carefully titrated therapeutic stimulation at specific targets. Once implanted, the electrical stimulation parameters at each electrode contact can be modified. Iteratively adjusting the stimulation parameters enables testing for the optimal stimulation settings. Due to the large parameter space, the currently employed empirical testing of individual parameters based on acute clinical response is not sustainable. Within the constraints of short clinical visits, optimization is particularly challenging when clinical features lack immediate feedback, as seen in DBS for dystonia and depression and with the cognitive and axial side effects of DBS for Parkinson's disease. A personalized approach to stimulation parameter selection is desirable as the increasing complexity of modern DBS devices also expands the number of available parameters. This review describes three emerging imaging and electrophysiological methods of personalizing DBS programming. Normative connectome-base stimulation utilizes large datasets of normal or disease-matched connectivity imaging. The stimulation location for an individual patient can then be varied to engage regions associated with optimal connectivity. Electrophysiology-guided open- and closed-loop stimulation capitalizes on the electrophysiological recording capabilities of modern implanted devices to individualize stimulation parameters based on biomarkers of success or symptom onset. Finally, individual functional MRI (fMRI)-based approaches use fMRI during active stimulation to identify parameters resulting in characteristic patterns of functional engagement associated with long-term treatment response. Each method provides different but complementary information, and maximizing treatment efficacy likely requires a combined approach.
Collapse
Affiliation(s)
- Brendan Santyr
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada
- Department of Clinical Neurological Sciences, Western University, London, ON, Canada
| | - Alexandre Boutet
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | | | - Jürgen Germann
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada
- Krembil Brain Institute, Toronto, ON, Canada
- Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada
| | | | - Alfonso Fasano
- Krembil Brain Institute, Toronto, ON, Canada
- Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada
- Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, UHN, Toronto, ON, Canada
| | - Andres M Lozano
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada
- Krembil Brain Institute, Toronto, ON, Canada
- Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada
| | - Walter Kucharczyk
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
13
|
Butenko K, Neudorfer C, Dembek TA, Hollunder B, Meyer GM, Li N, Oxenford S, Bahners BH, Al-Fatly B, Lofredi R, Gordon EM, Dosenbach NUF, Ganos C, Hallett M, Jinnah HA, Starr PA, Ostrem JL, Wu Y, Zhang C, Fox MD, Horn A. Engaging dystonia networks with subthalamic stimulation. Proc Natl Acad Sci U S A 2025; 122:e2417617122. [PMID: 39773021 PMCID: PMC11745339 DOI: 10.1073/pnas.2417617122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Accepted: 12/02/2024] [Indexed: 01/11/2025] Open
Abstract
Deep brain stimulation is an efficacious treatment for dystonia. While the internal pallidum serves as the primary target, recently, stimulation of the subthalamic nucleus (STN) has been investigated. However, optimal targeting within this structure and its surroundings have not been studied in depth. Indeed, historical targets that have been used for surgical treatment of dystonia are directly adjacent to the STN. Further, multiple types of dystonia exist, and outcomes are variable, suggesting that not all types would profit maximally from the same target. Therefore, a thorough investigation of neural substrates underlying stimulation effects on dystonia signs and symptoms is warranted. Here, we analyze a multicenter cohort of isolated dystonia patients with subthalamic implantations (N = 58) and relate their stimulation sites to improvements of appendicular and cervical symptoms as well as blepharospasm. Stimulation of the ventral oral posterior nucleus of thalamus and surrounding regions were associated with improvements in cervical dystonia, while stimulation of the dorsolateral STN was associated with improvements in limb dystonia and blepharospasm. This dissociation was matched by structural connectivity analysis, where the cerebellothalamic, corticospinal, and pallidosubthalamic tracts were associated with improvements of cervical dystonia, while hyperdirect and subthalamopallidal pathways with alleviation of limb dystonia and blepharospasm. On the level of functional networks, improvements of limb dystonia were associated with connectivity to the corresponding somatotopic regions in the primary motor cortex, while alleviation of cervical dystonia to the cingulo-opercular network. These findings shed light on the pathophysiology of dystonia and may guide DBS targeting and programming in the future.
Collapse
Affiliation(s)
- Konstantin Butenko
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
| | - Clemens Neudorfer
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA02114
| | - Till A. Dembek
- Department of Neurology, Faculty of Medicine, University of Cologne, Cologne50937, Germany
| | - Barbara Hollunder
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
- Einstein Center for Neurosciences Berlin, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
- Berlin School of Mind and Brain, Humboldt—Universität zu Berlin, Berlin10117, Germany
| | - Garance M. Meyer
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
| | - Ningfei Li
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
| | - Simón Oxenford
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
| | - Bahne H. Bahners
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf40225, Germany
- Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf40225, Germany
| | - Bassam Al-Fatly
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
| | - Roxanne Lofredi
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
| | - Evan M. Gordon
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO63110
| | - Nico U. F. Dosenbach
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO63110
- Department of Neurology, Washington University School of Medicine, St. Louis, MO63108
- Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO63130
| | - Christos Ganos
- Movement Disorder Clinic, Edmond J. Safra Program in Parkinson’s Disease, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, ONM5T 2S6, Canada
| | - Mark Hallett
- Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD20892
| | | | - Philip A. Starr
- Department of Neurological Surgery, University of California, San Francisco, CA94143
| | - Jill L. Ostrem
- Movement Disorders and Neuromodulation Centre, Department of Neurology, University of California, San Francisco, CA94143
| | - Yiwen Wu
- Department of Neurology & Institute of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai200025, China
| | - ChenCheng Zhang
- Department of Neurosurgery, Rujin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai200025, China
| | - Michael D. Fox
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
| | - Andreas Horn
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA02115
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA02114
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
- Einstein Center for Neurosciences Berlin, Charité—Universitätsmedizin Berlin, Berlin10117, Germany
| |
Collapse
|
14
|
Slepneva N, Basich‐Pease G, Reid L, Frank AC, Norbu T, Krystal AD, Sugrue LP, Motzkin JC, Larson PS, Starr PA, Morrison MA, Lee AM. Therapeutic DBS for OCD Suppresses the Default Mode Network. Hum Brain Mapp 2024; 45:e70106. [PMID: 39719929 PMCID: PMC11668941 DOI: 10.1002/hbm.70106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2024] [Revised: 11/26/2024] [Accepted: 12/04/2024] [Indexed: 12/26/2024] Open
Abstract
Deep brain stimulation (DBS) of the anterior limb of the internal capsule (ALIC) is a circuit-based treatment for severe, refractory obsessive-compulsive disorder (OCD). The therapeutic effects of DBS are hypothesized to be mediated by direct modulation of a distributed cortico-striato-thalmo-cortical network underlying OCD symptoms. However, the exact underlying mechanism by which DBS exerts its therapeutic effects still remains unclear. In five participants receiving DBS for severe, refractory OCD (3 responders, 2 non-responders), we conducted a DBS On/Off cycling paradigm during the acquisition of functional MRI (23 fMRI runs) to determine the network effects of stimulation across a variety of bipolar configurations. We also performed tractography using diffusion-weighted imaging (DWI) to relate the functional impact of DBS to the underlying structural connectivity between active stimulation contacts and functional brain networks. We found that therapeutic DBS had a distributed effect, suppressing BOLD activity within regions such as the orbitofrontal cortex, dorsomedial prefrontal cortex, and subthalamic nuclei compared to non-therapeutic configurations. Many of the regions suppressed by therapeutic DBS were components of the default mode network (DMN). Moreover, the estimated stimulation field from the therapeutic configurations exhibited significant structural connectivity to core nodes of the DMN. Based upon these findings, we hypothesize that the suppression of the DMN by ALIC DBS is mediated by interruption of communication through structural white matter connections surrounding the DBS active contacts.
Collapse
Affiliation(s)
- Natalya Slepneva
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Genevieve Basich‐Pease
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Lee Reid
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Adam C. Frank
- Department of Psychiatry and Behavioral SciencesKeck School of Medicine of USCLos AngelesCaliforniaUSA
| | - Tenzin Norbu
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Andrew D. Krystal
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Leo P. Sugrue
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Julian C. Motzkin
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Neurology and Anesthesia and Perioperative CareUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Paul S. Larson
- Department of NeurosurgeryUniversity of ArizonaTucsonArizonaUSA
| | - Philip A. Starr
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Neurological SurgeryUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Melanie A. Morrison
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - A. Moses Lee
- Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| |
Collapse
|
15
|
von Leupoldt A, Karachi C, Jelinčić V. Relieving dyspnoea through the brain. Eur Respir J 2024; 64:2401828. [PMID: 39638363 DOI: 10.1183/13993003.01828-2024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2024] [Accepted: 09/21/2024] [Indexed: 12/07/2024]
Affiliation(s)
| | - Carine Karachi
- Hôpital Pitié-Salpêtrière, AP-HP Sorbonne, Paris, France
| | | |
Collapse
|
16
|
Rodriguez-Rojas R, Máñez-Miró JU, Pineda-Pardo JA, Del Álamo M, Martínez-Fernández R, Obeso JA. Functional anatomy of the subthalamic nucleus and the pathophysiology of cardinal features of Parkinson's disease unraveled by focused ultrasound ablation. SCIENCE ADVANCES 2024; 10:eadr9891. [PMID: 39576853 PMCID: PMC11584003 DOI: 10.1126/sciadv.adr9891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 10/23/2024] [Indexed: 11/24/2024]
Abstract
The subthalamic nucleus (STN) modulates basal ganglia output and plays a fundamental role in the pathophysiology of Parkinson's disease (PD). Blockade/ablation of the STN improves motor signs in PD. We assessed the topography of focused ultrasound subthalamotomy (n = 39) by voxel-based lesion-symptom mapping to identify statistically validated brain voxels with the optimal effect against each cardinal feature and their respective cortical connectivity patterns by diffusion-weighted tractography. Bradykinesia and rigidity amelioration were associated with ablation of the rostral motor STN subregion connected to the supplementary motor and premotor cortices, whereas antitremor effect was explained by lesioning the posterolateral STN projection to the primary motor cortex. These findings were corroborated prospectively in another PD cohort (n = 12). This work concurs with recent deep brain stimulation findings that suggest different corticosubthalamic circuits underlying each PD cardinal feature. Our results provide sound evidence in humans of segregated anatomy of subthalamic-cortical connections and their distinct role in PD pathophysiology and normal motor control.
Collapse
Affiliation(s)
- Rafael Rodriguez-Rojas
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
- Facultad de Tecnología y Ciencia, Universidad Camilo José Cela, Madrid, Spain
- Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain
- CIBERNED, Instituto de Salud Carlos III, Madrid, Spain
| | - Jorge U Máñez-Miró
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
- PhD Program in Neuroscience, Autónoma de Madrid University-Cajal Institute, Madrid, Spain
| | - José A Pineda-Pardo
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
- Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain
- CIBERNED, Instituto de Salud Carlos III, Madrid, Spain
| | - Marta Del Álamo
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
| | - Raúl Martínez-Fernández
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
- Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain
- CIBERNED, Instituto de Salud Carlos III, Madrid, Spain
| | - José A Obeso
- HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
- Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain
- CIBERNED, Instituto de Salud Carlos III, Madrid, Spain
- Medical School, CEU-San Pablo University, Madrid, Spain
| |
Collapse
|
17
|
Gell M, Noble S, Laumann TO, Nelson SM, Tervo-Clemmens B. Psychiatric neuroimaging designs for individualised, cohort, and population studies. Neuropsychopharmacology 2024; 50:29-36. [PMID: 39143320 PMCID: PMC11525483 DOI: 10.1038/s41386-024-01918-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 05/30/2024] [Accepted: 06/11/2024] [Indexed: 08/16/2024]
Abstract
Psychiatric neuroimaging faces challenges to rigour and reproducibility that prompt reconsideration of the relative strengths and limitations of study designs. Owing to high resource demands and varying inferential goals, current designs differentially emphasise sample size, measurement breadth, and longitudinal assessments. In this overview and perspective, we provide a guide to the current landscape of psychiatric neuroimaging study designs with respect to this balance of scientific goals and resource constraints. Through a heuristic data cube contrasting key design features, we discuss a resulting trade-off among small sample, precision longitudinal studies (e.g., individualised studies and cohorts) and large sample, minimally longitudinal, population studies. Precision studies support tests of within-person mechanisms, via intervention and tracking of longitudinal course. Population studies support tests of generalisation across multifaceted individual differences. A proposed reciprocal validation model (RVM) aims to recursively leverage these complementary designs in sequence to accumulate evidence, optimise relative strengths, and build towards improved long-term clinical utility.
Collapse
Affiliation(s)
- Martin Gell
- Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
- Institute of Neuroscience and Medicine (INM-7: Brain & Behaviour), Research Centre Jülich, Jülich, Germany.
- Masonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
| | - Stephanie Noble
- Psychology Department, Northeastern University, Boston, MA, USA
- Bioengineering Department, Northeastern University, Boston, MA, USA
- Center for Cognitive and Brain Health, Northeastern University, Boston, MA, USA
| | - Timothy O Laumann
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
| | - Steven M Nelson
- Masonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA
- Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
| | - Brenden Tervo-Clemmens
- Masonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
- Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
- Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN, USA.
| |
Collapse
|
18
|
Warren AEL, Raguž M, Friedrich H, Schaper FLWVJ, Tasserie J, Snider SB, Li J, Chua MMJ, Butenko K, Friedrich MU, Jha R, Iglesias JE, Carney PW, Fischer D, Fox MD, Boes AD, Edlow BL, Horn A, Chudy D, Rolston JD. A human brain network linked to restoration of consciousness after deep brain stimulation. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.10.17.24314458. [PMID: 39484242 PMCID: PMC11527079 DOI: 10.1101/2024.10.17.24314458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/03/2024]
Abstract
Disorders of consciousness (DoC) are states of impaired arousal or awareness. Deep brain stimulation (DBS) is a potential treatment, but outcomes vary, possibly due to differences in patient characteristics, electrode placement, or stimulation of specific brain networks. We studied 40 patients with DoC who underwent DBS targeting the thalamic centromedian-parafascicular complex. Better-preserved gray matter, especially in the striatum, correlated with consciousness improvement. Stimulation was most effective when electric fields extended into parafascicular and subparafascicular nuclei-ventral to the centromedian nucleus, near the midbrain-and when it engaged projection pathways of the ascending arousal network, including the hypothalamus, brainstem, and frontal lobe. Moreover, effective DBS sites were connected to networks similar to those underlying impaired consciousness due to generalized absence seizures and acquired lesions. These findings support the therapeutic potential of DBS for DoC, emphasizing the importance of precise targeting and revealing a broader link between effective DoC treatment and mechanisms underlying other conscciousness-impairing conditions.
Collapse
Affiliation(s)
- Aaron E L Warren
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Marina Raguž
- Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia
- School of Medicine, Catholic University of Croatia, Zagreb, Croatia
| | - Helen Friedrich
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- University of Wurzburg, Faculty of Medicine, Josef-Schneider-Str. 2, 97080, Wurzburg, Germany
| | - Frederic L W V J Schaper
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jordy Tasserie
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Samuel B Snider
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jian Li
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Melissa M J Chua
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Konstantin Butenko
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Maximilian U Friedrich
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Rohan Jha
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Juan E Iglesias
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Centre for Medical Image Computing, University College London, London, United Kingdom
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Patrick W Carney
- Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
| | - David Fischer
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Michael D Fox
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Aaron D Boes
- Departments of Neurology, Pediatrics, and Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA
| | - Brian L Edlow
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Andreas Horn
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Darko Chudy
- Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia
- Department of Surgery, School of Medicine, University of Zagreb, Zagreb, Croatia
| | - John D Rolston
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA, USA
- Center for Brain Circuit Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
19
|
Li Q, Wang W, Yin H, Zou K, Jiao Y, Zhang Y. One-Dimensional Implantable Sensors for Accurately Monitoring Physiological and Biochemical Signals. RESEARCH (WASHINGTON, D.C.) 2024; 7:0507. [PMID: 39417041 PMCID: PMC11480832 DOI: 10.34133/research.0507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/11/2024] [Revised: 09/12/2024] [Accepted: 09/27/2024] [Indexed: 10/19/2024]
Abstract
In recent years, one-dimensional (1D) implantable sensors have received considerable attention and rapid development in the biomedical field due to their unique structural characteristics and high integration capability. These sensors can be implanted into the human body with minimal invasiveness, facilitating real-time and accurate monitoring of various physiological and pathological parameters. This review examines the latest advancements in 1D implantable sensors, focusing on the material design of sensors, device integration, implantation methods, and the construction of the stable sensor-tissue interface. Furthermore, a comprehensive overview is provided regarding the applications and future research directions for 1D implantable sensors with an ultimate aim to promote their utilization in personalized healthcare and precision medicine.
Collapse
Affiliation(s)
| | | | | | - Kuangyi Zou
- National Laboratory of Solid State Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Chemistry and Biomedicine Innovation Center, Collaborative Innovation Center of Advanced Microstructures, College of Engineering and Applied Sciences,
Nanjing University, Nanjing 210023, China
| | - Yiding Jiao
- National Laboratory of Solid State Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Chemistry and Biomedicine Innovation Center, Collaborative Innovation Center of Advanced Microstructures, College of Engineering and Applied Sciences,
Nanjing University, Nanjing 210023, China
| | - Ye Zhang
- National Laboratory of Solid State Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Chemistry and Biomedicine Innovation Center, Collaborative Innovation Center of Advanced Microstructures, College of Engineering and Applied Sciences,
Nanjing University, Nanjing 210023, China
| |
Collapse
|
20
|
Marchant JK, Ferris NG, Grass D, Allen MS, Gopalakrishnan V, Olchanyi M, Sehgal D, Sheft M, Strom A, Bilgic B, Edlow B, Hillman EMC, Juttukonda MR, Lewis L, Nasr S, Nummenmaa A, Polimeni JR, Tootell RBH, Wald LL, Wang H, Yendiki A, Huang SY, Rosen BR, Gollub RL. Mesoscale Brain Mapping: Bridging Scales and Modalities in Neuroimaging - A Symposium Review. Neuroinformatics 2024; 22:679-706. [PMID: 39312131 PMCID: PMC11579116 DOI: 10.1007/s12021-024-09686-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2024] [Indexed: 10/20/2024]
Abstract
Advances in the spatiotemporal resolution and field-of-view of neuroimaging tools are driving mesoscale studies for translational neuroscience. On October 10, 2023, the Center for Mesoscale Mapping (CMM) at the Massachusetts General Hospital (MGH) Athinoula A. Martinos Center for Biomedical Imaging and the Massachusetts Institute of Technology (MIT) Health Sciences Technology based Neuroimaging Training Program (NTP) hosted a symposium exploring the state-of-the-art in this rapidly growing area of research. "Mesoscale Brain Mapping: Bridging Scales and Modalities in Neuroimaging" brought together researchers who use a broad range of imaging techniques to study brain structure and function at the convergence of the microscopic and macroscopic scales. The day-long event centered on areas in which the CMM has established expertise, including the development of emerging technologies and their application to clinical translational needs and basic neuroscience questions. The in-person symposium welcomed more than 150 attendees, including 57 faculty members, 61 postdoctoral fellows, 35 students, and four industry professionals, who represented institutions at the local, regional, and international levels. The symposium also served the training goals of both the CMM and the NTP. The event content, organization, and format were planned collaboratively by the faculty and trainees. Many CMM faculty presented or participated in a panel discussion, thus contributing to the dissemination of both the technologies they have developed under the auspices of the CMM and the findings they have obtained using those technologies. NTP trainees who benefited from the symposium included those who helped to organize the symposium and/or presented posters and gave "flash" oral presentations. In addition to gaining experience from presenting their work, they had opportunities throughout the day to engage in one-on-one discussions with visiting scientists and other faculty, potentially opening the door to future collaborations. The symposium presentations provided a deep exploration of the many technological advances enabling progress in structural and functional mesoscale brain imaging. Finally, students worked closely with the presenting faculty to develop this report summarizing the content of the symposium and putting it in the broader context of the current state of the field to share with the scientific community. We note that the references cited here include conference abstracts corresponding to the symposium poster presentations.
Collapse
Affiliation(s)
- Joshua K Marchant
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA.
| | - Natalie G Ferris
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
- Harvard Biophysics Graduate Program, Cambridge, MA, USA.
| | - Diana Grass
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Magdelena S Allen
- Massachusetts Institute of Technology, Cambridge, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Vivek Gopalakrishnan
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Mark Olchanyi
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Devang Sehgal
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Maxina Sheft
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Amelia Strom
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA
| | - Berkin Bilgic
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Brian Edlow
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Elizabeth M C Hillman
- Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA
- Department of Biomedical Engineering, Columbia University, New York, NY, USA
- Department of Radiology, Columbia University, New York, NY, USA
| | - Meher R Juttukonda
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Laura Lewis
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA
- Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Shahin Nasr
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Aapo Nummenmaa
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Jonathan R Polimeni
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Roger B H Tootell
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Lawrence L Wald
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Hui Wang
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Anastasia Yendiki
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Susie Y Huang
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
| | - Bruce R Rosen
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Randy L Gollub
- Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| |
Collapse
|
21
|
Yang W, Lian K, Ye J, Cheng Y, Xu X. Analyses of single-cell and bulk RNA sequencing combined with machine learning reveal the expression patterns of disrupted mitophagy in schizophrenia. Front Psychiatry 2024; 15:1429437. [PMID: 39355378 PMCID: PMC11442249 DOI: 10.3389/fpsyt.2024.1429437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Accepted: 08/29/2024] [Indexed: 10/03/2024] Open
Abstract
Background Mitochondrial dysfunction is an important factor in the pathogenesis of schizophrenia. However, the relationship between mitophagy and schizophrenia remains to be elucidated. Methods Single-cell RNA sequencing datasets of peripheral blood and brain organoids from SCZ patients and healthy controls were retrieved. Mitophagy-related genes that were differentially expressed between the two groups were screened. The diagnostic model based on key mitophagy genes was constructed using two machine learning methods, and the relationship between mitophagy and immune cells was analyzed. Single-cell RNA sequencing data of brain organoids was used to calculate the mitophagy score (Mitoscore). Results We found 7 key mitophagy genes to construct a diagnostic model. The mitophagy genes were related to the infiltration of neutrophils, activated dendritic cells, resting NK cells, regulatory T cells, resting memory T cells, and CD8 T cells. In addition, we identified 12 cell clusters based on the Mitoscore, and the most abundant neurons were further divided into three subgroups. Results at the single-cell level showed that Mitohigh_Neuron established a novel interaction with endothelial cells via SPP1 signaling pathway, suggesting their distinct roles in SCZ pathogenesis. Conclusion We identified a mitophagy signature for schizophrenia that provides new insights into disease pathogenesis and new possibilities for its diagnosis and treatment.
Collapse
Affiliation(s)
- Wei Yang
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Department of Psychiatry, The Second People’s Hospital of Yuxi, Yuxi, Yunnan, China
- Yuxi Hospital affiliated to Kunming University of Science and Technology, Yuxi, Yunnan, China
| | - Kun Lian
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| | - Jing Ye
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| | - Yuqi Cheng
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Schizophrenia Research Program, Yunnan Clinical Research Center for Mental Disorders, Kunming, Yunnan, China
| | - Xiufeng Xu
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
- Schizophrenia Research Program, Yunnan Clinical Research Center for Mental Disorders, Kunming, Yunnan, China
| |
Collapse
|
22
|
Ricci A, Rubino E, Serra GP, Wallén-Mackenzie Å. Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: Insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents. Neuropharmacology 2024; 256:110003. [PMID: 38789078 DOI: 10.1016/j.neuropharm.2024.110003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Revised: 04/26/2024] [Accepted: 05/14/2024] [Indexed: 05/26/2024]
Abstract
Neuromodulation such as deep brain stimulation (DBS) is advancing as a clinical intervention in several neurological and neuropsychiatric disorders, including Parkinson's disease, dystonia, tremor, and obsessive-compulsive disorder (OCD) for which DBS is already applied to alleviate severely afflicted individuals of symptoms. Tourette syndrome and drug addiction are two additional disorders for which DBS is in trial or proposed as treatment. However, some major remaining obstacles prevent this intervention from reaching its full therapeutic potential. Side-effects have been reported, and not all DBS-treated individuals are relieved of their symptoms. One major target area for DBS electrodes is the subthalamic nucleus (STN) which plays important roles in motor, affective and associative functions, with impact on for example movement, motivation, impulsivity, compulsivity, as well as both reward and aversion. The multifunctionality of the STN is complex. Decoding the anatomical-functional organization of the STN could enhance strategic targeting in human patients. The STN is located in close proximity to zona incerta (ZI) and the para-subthalamic nucleus (pSTN). Together, the STN, pSTN and ZI form a highly heterogeneous and clinically important brain area. Rodent-based experimental studies, including opto- and chemogenetics as well as viral-genetic tract tracings, provide unique insight into complex neuronal circuitries and their impact on behavior with high spatial and temporal precision. This research field has advanced tremendously over the past few years. Here, we provide an inclusive review of current literature in the pre-clinical research fields centered around STN, pSTN and ZI in laboratory mice and rats; the three highly heterogeneous and enigmatic structures brought together in the context of relevance for treatment strategies. Specific emphasis is placed on methods of manipulation and behavioral impact.
Collapse
Affiliation(s)
- Alessia Ricci
- Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
| | - Eleonora Rubino
- Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
| | - Gian Pietro Serra
- Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
| | - Åsa Wallén-Mackenzie
- Uppsala University, Department of Organism Biology, 756 32 Uppsala, Sweden; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
| |
Collapse
|
23
|
Doyle H, Garnaat S, McLaughlin N, Desrochers TM. Cognitive sequences in obsessive-compulsive disorder are supported by frontal cortex ramping activity and mediated by symptom severity. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.07.28.605508. [PMID: 39131400 PMCID: PMC11312446 DOI: 10.1101/2024.07.28.605508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 08/13/2024]
Abstract
Completing sequences is part of everyday life. Many such sequences can be considered abstract - that is, defined by a rule that governs the order but not the identity of individual steps (e.g., getting dressed for work). Over-engagement in ritualistic and repetitive behaviors seen in obsessive-compulsive disorder (OCD) suggests that abstract sequences may be disrupted in this disorder. Previous work has shown the necessity of the rostrolateral prefrontal cortex (RLPFC) for abstract sequence processing and that neural activity increases (ramps) in this region across sequences (Desrochers et al., 2015, 2019). Neurobiological models of the cortico-striatal-thalamo-cortical (CSTC) loops describe prefrontal circuitry connected to RLPFC and that is believed to be dysfunctional in OCD. As a potential extension of these models, we hypothesized that neural dynamics of RLPFC could be disrupted in OCD during abstract sequence engagement. We found that neural dynamics in RLPFC did not differ between OCD and healthy controls (HCs), but that increased ramping in pregenual anterior cingulate cortex (rACC), and superior frontal sulcus (SFS) dissociates these two groups in an abstract sequence paradigm. Further, we found that anxiety and depressive symptoms mediated the relationship between observed neural activity and behavioral differences observed in the task. This study highlights the importance of investigating ramping as a relevant neural dynamic during sequences and suggests expansion of current neurobiological models to include regions that support sequential behavior in OCD. Further, our results may point to novel regions to consider for neuromodulatory treatments of OCD in the future.
Collapse
Affiliation(s)
- Hannah Doyle
- Department of Neuroscience, Brown University, 02906
| | - Sarah Garnaat
- Department of Psychiatry, Geisel School of Medicine at Dartmouth College & Dartmouth-Hitchcock Medical Center, 03766
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, 02903
- Butler Hospital, 02906
| | - Nicole McLaughlin
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, 02903
- Butler Hospital, 02906
| | - Theresa M. Desrochers
- Department of Neuroscience, Brown University, 02906
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, 02903
- Robert J. and Nancy D. Carney Institute for Brain Sciences, Brown University, 02906
| |
Collapse
|
24
|
Ronde M, van der Zee EA, Kas MJH. Default mode network dynamics: An integrated neurocircuitry perspective on social dysfunction in human brain disorders. Neurosci Biobehav Rev 2024; 164:105839. [PMID: 39097251 DOI: 10.1016/j.neubiorev.2024.105839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Revised: 07/25/2024] [Accepted: 07/31/2024] [Indexed: 08/05/2024]
Abstract
Our intricate social brain is implicated in a range of brain disorders, where social dysfunction emerges as a common neuropsychiatric feature cutting across diagnostic boundaries. Understanding the neurocircuitry underlying social dysfunction and exploring avenues for its restoration could present a transformative and transdiagnostic approach to overcoming therapeutic challenges in these disorders. The brain's default mode network (DMN) plays a crucial role in social functioning and is implicated in various neuropsychiatric conditions. By thoroughly examining the current understanding of DMN functionality, we propose that the DMN integrates diverse social processes, and disruptions in brain communication at regional and network levels due to disease hinder the seamless integration of these social functionalities. Consequently, this leads to an altered balance between self-referential and attentional processes, alongside a compromised ability to adapt to social contexts and anticipate future social interactions. Looking ahead, we explore how adopting an integrated neurocircuitry perspective on social dysfunction could pave the way for innovative therapeutic approaches to address brain disorders.
Collapse
Affiliation(s)
- Mirthe Ronde
- Groningen Institute for Evolutionary Life Sciences (GELIFES), Neurobiology, University of Groningen, Nijenborgh 7, Groningen 9747 AG, the Netherlands
| | - Eddy A van der Zee
- Groningen Institute for Evolutionary Life Sciences (GELIFES), Neurobiology, University of Groningen, Nijenborgh 7, Groningen 9747 AG, the Netherlands
| | - Martien J H Kas
- Groningen Institute for Evolutionary Life Sciences (GELIFES), Neurobiology, University of Groningen, Nijenborgh 7, Groningen 9747 AG, the Netherlands.
| |
Collapse
|
25
|
Geng X, Quan Z, Zhang R, Zhu G, Nie Y, Wang S, Rolls E, Zhang J, Hu L. Subthalamic and pallidal oscillations and their couplings reflect dystonia severity and improvements by deep brain stimulation. Neurobiol Dis 2024; 199:106581. [PMID: 38936434 DOI: 10.1016/j.nbd.2024.106581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 06/05/2024] [Accepted: 06/25/2024] [Indexed: 06/29/2024] Open
Abstract
BACKGROUND Deep brain stimulation (DBS) targeting the globus pallidus internus (GPi) and subthalamic nucleus (STN) is employed for the treatment of dystonia. Pallidal low-frequency oscillations have been proposed as a pathophysiological marker for dystonia. However, the role of subthalamic oscillations and STN-GPi coupling in relation to dystonia remains unclear. OBJECTIVE We aimed to explore oscillatory activities within the STN-GPi circuit and their correlation with the severity of dystonia and efficacy achieved by DBS treatment. METHODS Local field potentials were recorded simultaneously from the STN and GPi from 13 dystonia patients. Spectral power analysis was conducted for selected frequency bands from both nuclei, while power correlation and the weighted phase lag index were used to evaluate power and phase couplings between these two nuclei, respectively. These features were incorporated into generalized linear models to assess their associations with dystonia severity and DBS efficacy. RESULTS The results revealed that pallidal theta power, subthalamic beta power and subthalamic-pallidal theta phase coupling and beta power coupling all correlated with clinical severity. The model incorporating all selected features predicts empirical clinical scores and DBS-induced improvements, whereas the model relying solely on pallidal theta power failed to demonstrate significant correlations. CONCLUSIONS Beyond pallidal theta power, subthalamic beta power, STN-GPi couplings in theta and beta bands, play a crucial role in understanding the pathophysiological mechanism of dystonia and developing optimal strategies for DBS.
Collapse
Affiliation(s)
- Xinyi Geng
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.
| | - Zhaoyu Quan
- Academy for Engineering and Technology, Fudan University, Shanghai, China
| | - Ruili Zhang
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, China
| | - Guanyu Zhu
- Department of Neurosurgery, Beijing Tian-Tan Hospital, Beijing Neurosurgical Institute, Capital Medical University, China
| | - Yingnan Nie
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, China
| | - Shouyan Wang
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, China
| | - Edmund Rolls
- Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; Oxford Centre for Computational Neuroscience, University of Oxford, Oxford, UK
| | - Jianguo Zhang
- Department of Neurosurgery, Beijing Tian-Tan Hospital, Beijing Neurosurgical Institute, Capital Medical University, China.
| | - Li Hu
- CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China
| |
Collapse
|
26
|
Rassoulou F, Steina A, Hartmann CJ, Vesper J, Butz M, Schnitzler A, Hirschmann J. Exploring the electrophysiology of Parkinson's disease with magnetoencephalography and deep brain recordings. Sci Data 2024; 11:889. [PMID: 39147788 PMCID: PMC11327342 DOI: 10.1038/s41597-024-03768-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Accepted: 08/08/2024] [Indexed: 08/17/2024] Open
Abstract
Aberrant information processing in the basal ganglia and connected cortical areas are key to many neurological movement disorders such as Parkinson's disease. Investigating the electrophysiology of this system is difficult in humans because non-invasive methods, such as electroencephalography or magnetoencephalography, have limited sensitivity to deep brain areas. Recordings from electrodes implanted for therapeutic deep brain stimulation, in contrast, provide clear deep brain signals but are not suited for studying cortical activity. Therefore, we combine magnetoencephalography and local field potential recordings from deep brain stimulation electrodes in individuals with Parkinson's disease. Here, we make these data available, inviting a broader scientific community to explore the dynamics of neural activity in the subthalamic nucleus and its functional connectivity to cortex. The dataset encompasses resting-state recordings, plus two motor tasks: static forearm extension and self-paced repetitive fist clenching. Most patients were recorded both in the medicated and the unmedicated state. Along with the raw data, we provide metadata on channels, events and scripts for pre-processing to help interested researchers get started.
Collapse
Affiliation(s)
- Fayed Rassoulou
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Alexandra Steina
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Christian J Hartmann
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
- Center for Movement Disorders and Neuromodulation, Department of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Jan Vesper
- Department of Functional Neurosurgery and Stereotaxy, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Markus Butz
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Alfons Schnitzler
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
- Center for Movement Disorders and Neuromodulation, Department of Neurology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany
| | - Jan Hirschmann
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225, Düsseldorf, Germany.
| |
Collapse
|
27
|
Slepneva N, Basich-Pease G, Reid L, Frank AC, Norbu T, Krystal AD, Sugrue LP, Motzkin JC, Larson PS, Starr PA, Morrison MA, Lee AM. Therapeutic DBS for OCD Suppresses the Default Mode Network. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.07.21.601827. [PMID: 39091832 PMCID: PMC11291060 DOI: 10.1101/2024.07.21.601827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/04/2024]
Abstract
Background Deep brain stimulation (DBS) of the anterior limb of the internal capsule (ALIC) is an emerging treatment for severe, refractory obsessive-compulsive disorder (OCD). The therapeutic effects of DBS are hypothesized to be mediated by direct modulation of a distributed cortico-striato-thalmo-cortical network underlying OCD symptoms. However, the exact underlying mechanism by which DBS exerts its therapeutic effects still remains unclear. Method In five participants receiving DBS for severe, refractory OCD (3 responders, 2 non-responders), we conducted a DBS On/Off cycling paradigm during the acquisition of functional MRI to determine the network effects of stimulation across a variety of bipolar configurations. We also performed tractography using diffusion-weighted imaging (DWI) to relate the functional impact of DBS to the underlying structural connectivity between active stimulation contacts and functional brain networks. Results We found that therapeutic DBS had a distributed effect, suppressing BOLD activity within regions such as the orbitofrontal cortex, dorsomedial prefrontal cortex, and subthalamic nuclei compared to non-therapeutic configurations. Many of the regions suppressed by therapeutic DBS were components of the default mode network (DMN). Moreover, the estimated stimulation field from the therapeutic configurations exhibited significant structural connectivity to core nodes of the DMN. Conclusions Therapeutic DBS for OCD suppresses BOLD activity within a distributed set of regions within the DMN relative to non-therapeutic configurations. We propose that these effects may be mediated by interruption of communication through structural white matter connections surrounding the DBS active contacts.
Collapse
Affiliation(s)
- Natalya Slepneva
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Genevieve Basich-Pease
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Lee Reid
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
- Department of Radiology and Biomedical Imaging, University of California, San Francisco
| | - Adam C. Frank
- Department of Psychiatry and Behavioral Sciences, Keck School of Medicine of USC
| | - Tenzin Norbu
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Andrew D Krystal
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| | - Leo P Sugrue
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Radiology and Biomedical Imaging, University of California, San Francisco
| | - Julian C Motzkin
- Weill Institute for Neurosciences, University of California, San Francisco
- Departments of Neurology and Anesthesia and Perioperative Care, University of California, San Francisco
| | | | - Philip A. Starr
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Neurological Surgery, University of California, San Francisco
| | - Melanie A. Morrison
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Radiology and Biomedical Imaging, University of California, San Francisco
| | - A Moses Lee
- Weill Institute for Neurosciences, University of California, San Francisco
- Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
| |
Collapse
|
28
|
Lee S, Williams ZM. Role of Prefrontal Cortex Circuitry in Maintaining Social Homeostasis. Biol Psychiatry 2024:S0006-3223(24)01455-0. [PMID: 39019390 PMCID: PMC11733069 DOI: 10.1016/j.biopsych.2024.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2024] [Revised: 06/12/2024] [Accepted: 07/11/2024] [Indexed: 07/19/2024]
Abstract
Homeostasis is a fundamental concept in biology and ensures the stability of life by maintaining the constancy of physiological processes. Recent years have witnessed a surge in research interest in these physiological processes, with a growing focus on understanding the mechanisms underlying social homeostasis. This shift in focus underscores our increasing understanding of the importance of social interactions and their impact on individual well-being. In this review, we explore the interconnected research across 3 primary categories: understanding the neural mechanisms influencing set points, defining contemporary factors that can disrupt social homeostasis, and identifying the potential contributions of social homeostatic failure in the development of psychiatric diseases. We also delve into the role of the prefrontal cortex and its circuitry in regulating social behavior, decision-making processes, and the manifestation of neuropsychiatric disorders, such as depression and anxiety. Finally, we examine the influence of more recent factors such as growing social media exposure and the COVID-19 pandemic on mental health, highlighting their disruptive effects. We also identify gaps in current literature through the analysis of research trends and propose future research directions to advance our understanding of social homeostasis, with implications for mental health interventions.
Collapse
Affiliation(s)
- SeungHyun Lee
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - Ziv M Williams
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts; Program in Neuroscience, Harvard Medical School, Boston, Massachusetts.
| |
Collapse
|
29
|
Meyer GM, Mosley PE. Tractography-Based Deep Brain Stimulation for Obsessive-Compulsive Disorder. Biol Psychiatry 2024; 96:80-81. [PMID: 38925716 DOI: 10.1016/j.biopsych.2024.05.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Accepted: 05/14/2024] [Indexed: 06/28/2024]
Affiliation(s)
- Garance M Meyer
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
| | - Philip E Mosley
- Clinical Brain Networks Group, Queensland Institute of Medical Research Berghofer Medical Research Institute, Herston, Queensland, Australia; Neurosciences Queensland, St. Andrew's War Memorial Hospital, Spring Hill, Queensland, Australia; Queensland Brain Institute, University of Queensland, St. Lucia, Queensland, Australia; Australian eHealth Research Centre, Commonwealth Scientific and Industrial Research Organisation Health and Biosecurity, Herston, Queensland, Australia
| |
Collapse
|
30
|
Rajamani N, Friedrich H, Butenko K, Dembek T, Lange F, Navrátil P, Zvarova P, Hollunder B, de Bie RMA, Odekerken VJJ, Volkmann J, Xu X, Ling Z, Yao C, Ritter P, Neumann WJ, Skandalakis GP, Komaitis S, Kalyvas A, Koutsarnakis C, Stranjalis G, Barbe M, Milanese V, Fox MD, Kühn AA, Middlebrooks E, Li N, Reich M, Neudorfer C, Horn A. Deep brain stimulation of symptom-specific networks in Parkinson's disease. Nat Commun 2024; 15:4662. [PMID: 38821913 PMCID: PMC11143329 DOI: 10.1038/s41467-024-48731-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Accepted: 05/13/2024] [Indexed: 06/02/2024] Open
Abstract
Deep Brain Stimulation can improve tremor, bradykinesia, rigidity, and axial symptoms in patients with Parkinson's disease. Potentially, improving each symptom may require stimulation of different white matter tracts. Here, we study a large cohort of patients (N = 237 from five centers) to identify tracts associated with improvements in each of the four symptom domains. Tremor improvements were associated with stimulation of tracts connected to primary motor cortex and cerebellum. In contrast, axial symptoms are associated with stimulation of tracts connected to the supplementary motor cortex and brainstem. Bradykinesia and rigidity improvements are associated with the stimulation of tracts connected to the supplementary motor and premotor cortices, respectively. We introduce an algorithm that uses these symptom-response tracts to suggest optimal stimulation parameters for DBS based on individual patient's symptom profiles. Application of the algorithm illustrates that our symptom-tract library may bear potential in personalizing stimulation treatment based on the symptoms that are most burdensome in an individual patient.
Collapse
Affiliation(s)
- Nanditha Rajamani
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
| | - Helen Friedrich
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
- University of Würzburg, Faculty of Medicine, Josef-Schneider-Str. 2, 97080, Würzburg, Germany
| | - Konstantin Butenko
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Till Dembek
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Neurology, University of Cologne, Cologne, Germany
| | - Florian Lange
- Department of Neurology, University Clinic of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
| | - Pavel Navrátil
- Department of Neurology, University Clinic of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
| | - Patricia Zvarova
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center Digital Future, Berlin, 10117, Germany
| | - Barbara Hollunder
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center Digital Future, Berlin, 10117, Germany
- Brain Simulation Section, Department of Neurology, Charité University Medicine Berlin and Berlin Institute of Health, Berlin, 10117, Germany
| | - Rob M A de Bie
- Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Vincent J J Odekerken
- Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Jens Volkmann
- Department of Neurology, University Clinic of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
| | - Xin Xu
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - Zhipei Ling
- Department of Neurosurgery, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan, 572000, China
| | - Chen Yao
- Department of Neurosurgery, The National Key Clinic Specialty, Shenzhen Key Laboratory of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China
| | - Petra Ritter
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center Digital Future, Berlin, 10117, Germany
- Brain Simulation Section, Department of Neurology, Charité University Medicine Berlin and Berlin Institute of Health, Berlin, 10117, Germany
- Bernstein center for Computational Neuroscience Berlin, Berlin, 10117, Germany
| | - Wolf-Julian Neumann
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Georgios P Skandalakis
- Section of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, 03756, USA
- Department of Neurosurgery, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, Athens, Greece
| | - Spyridon Komaitis
- Department of Neurosurgery, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, Athens, Greece
- Centre for Spinal Studies and Surgery, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Aristotelis Kalyvas
- Department of Neurosurgery, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, Athens, Greece
- Division of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
| | - Christos Koutsarnakis
- Department of Neurosurgery, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, Athens, Greece
| | - George Stranjalis
- Department of Neurosurgery, National and Kapodistrian University of Athens Medical School, Evangelismos General Hospital, Athens, Greece
| | - Michael Barbe
- Department of Neurology, University of Cologne, Cologne, Germany
| | - Vanessa Milanese
- Neurosurgical Division, Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil
- Department of Neurosurgery, Mayo Clinic, Florida, USA
- Movement Disorders and Neuromodulation Unit, DOMMO Clinic, São Paulo, Brazil
| | - Michael D Fox
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
- Harvard Medical School, Boston, MA, 02114, USA
- Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA
| | - Andrea A Kühn
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Einstein Center Digital Future, Berlin, 10117, Germany
- Brain Simulation Section, Department of Neurology, Charité University Medicine Berlin and Berlin Institute of Health, Berlin, 10117, Germany
| | | | - Ningfei Li
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Martin Reich
- Department of Neurology, University Clinic of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
| | - Clemens Neudorfer
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
- Harvard Medical School, Boston, MA, 02114, USA
- Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA
| | - Andreas Horn
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
- Harvard Medical School, Boston, MA, 02114, USA
- Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA
| |
Collapse
|
31
|
Unadkat P, Vo A, Ma Y, Peng S, Nguyen N, Niethammer M, Tang CC, Dhawan V, Ramdhani R, Fenoy A, Caminiti SP, Perani D, Eidelberg D. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: A network imaging marker of the treatment response. RESEARCH SQUARE 2024:rs.3.rs-4178280. [PMID: 38766007 PMCID: PMC11100869 DOI: 10.21203/rs.3.rs-4178280/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2024]
Abstract
Subthalamic nucleus deep brain stimulation (STN-DBS) alleviates motor symptoms of Parkinson's disease (PD), thereby improving quality of life. However, quantitative brain markers to evaluate DBS responses and select suitable patients for surgery are lacking. Here, we used metabolic brain imaging to identify a reproducible STN-DBS network for which individual expression levels increased with stimulation in proportion to motor benefit. Of note, measurements of network expression from metabolic and BOLD imaging obtained preoperatively predicted motor outcomes determined after DBS surgery. Based on these findings, we computed network expression in 175 PD patients, with time from diagnosis ranging from 0 to 21 years, and used the resulting data to predict the outcome of a potential STN-DBS procedure. While minimal benefit was predicted for patients with early disease, the proportion of potential responders increased after 4 years. Clinically meaningful improvement with stimulation was predicted in 18.9 - 27.3% of patients depending on disease duration.
Collapse
Affiliation(s)
| | - An Vo
- The Feinstein Institutes for Medical Research
| | - Yilong Ma
- Center for Neurosciences, Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
| | - Shichun Peng
- Center for Neurosciences, Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
| | | | | | | | | | - Ritesh Ramdhani
- Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
| | | | | | | | | |
Collapse
|
32
|
Gelineau-Morel R, Dlamini N, Bruss J, Cohen AL, Robertson A, Alexopoulos D, Smyser CD, Boes AD. Network localization of pediatric lesion-induced dystonia. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.04.06.24305421. [PMID: 38645071 PMCID: PMC11030491 DOI: 10.1101/2024.04.06.24305421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/23/2024]
Abstract
Objective Dystonia is a movement disorder defined by involuntary muscle contractions leading to abnormal postures or twisting and repetitive movements. Classically dystonia has been thought of as a disorder of the basal ganglia, but newer results in idiopathic dystonia and lesion-induced dystonia in adults point to broader motor network dysfunction spanning the basal ganglia, cerebellum, premotor cortex, sensorimotor, and frontoparietal regions. It is unclear whether a similar network is shared between different etiologies of pediatric lesion-induced dystonia. Methods Three cohorts of pediatric patients with lesion-induced dystonia were identified. The lesion etiologies included hypoxia, kernicterus, and stroke versus comparison subjects with acquired lesions not associated with dystonia. Multivariate lesion-symptom mapping and lesion network mapping were used to evaluate the anatomy and networks associated with dystonia. Results Multivariate lesion-symptom mapping showed that lesions of the putamen (stroke: r = 0.50, p <0.01; hypoxia, r = 0.64, p <0.001) and globus pallidus (kernicterus, r = 0.61, p <0.01) were associated with dystonia. Lesion network mapping using normative connectome data from healthy children demonstrated that these regional findings occurred within a common brain-wide network that involves the basal ganglia, anterior and medial cerebellum, and cortical regions that overlap the cingulo-opercular and somato-cognitive-action networks. Interpretation We interpret these findings as novel evidence for a unified dystonia brain network that involves the somato-cognitive-action network, which is involved in higher order coordination of movement. Elucidation of this network gives insight into the functional origins of dystonia and provides novel targets to investigate for therapeutic intervention.
Collapse
Affiliation(s)
- Rose Gelineau-Morel
- Division of Neurology, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri, USA
- University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
| | - Nomazulu Dlamini
- Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada
- Faculty of Medicine, University of Toronto, Toronto, Canada
| | - Joel Bruss
- Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
- Department of Neurology, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
| | - Alexander Li Cohen
- Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
| | - Amanda Robertson
- Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada
| | | | - Christopher D. Smyser
- Department of Neurology, Washington University, St Louis, Missouri, USA
- Department of Pediatrics, Washington University, St Louis, Missouri, USA
- Mallinckrodt Institute of Radiology, Washington University, St Louis, Missouri, USA
| | - Aaron D. Boes
- Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
- Department of Neurology, University of Iowa Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
- Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, USA Characters in title: 57, Characters in running head: 31
| |
Collapse
|
33
|
Hollunder B, Ostrem JL, Sahin IA, Rajamani N, Oxenford S, Butenko K, Neudorfer C, Reinhardt P, Zvarova P, Polosan M, Akram H, Vissani M, Zhang C, Sun B, Navratil P, Reich MM, Volkmann J, Yeh FC, Baldermann JC, Dembek TA, Visser-Vandewalle V, Alho EJL, Franceschini PR, Nanda P, Finke C, Kühn AA, Dougherty DD, Richardson RM, Bergman H, DeLong MR, Mazzoni A, Romito LM, Tyagi H, Zrinzo L, Joyce EM, Chabardes S, Starr PA, Li N, Horn A. Mapping dysfunctional circuits in the frontal cortex using deep brain stimulation. Nat Neurosci 2024; 27:573-586. [PMID: 38388734 PMCID: PMC10917675 DOI: 10.1038/s41593-024-01570-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Accepted: 01/05/2024] [Indexed: 02/24/2024]
Abstract
Frontal circuits play a critical role in motor, cognitive and affective processing, and their dysfunction may result in a variety of brain disorders. However, exactly which frontal domains mediate which (dys)functions remains largely elusive. We studied 534 deep brain stimulation electrodes implanted to treat four different brain disorders. By analyzing which connections were modulated for optimal therapeutic response across these disorders, we segregated the frontal cortex into circuits that had become dysfunctional in each of them. Dysfunctional circuits were topographically arranged from occipital to frontal, ranging from interconnections with sensorimotor cortices in dystonia, the primary motor cortex in Tourette's syndrome, the supplementary motor area in Parkinson's disease, to ventromedial prefrontal and anterior cingulate cortices in obsessive-compulsive disorder. Our findings highlight the integration of deep brain stimulation with brain connectomics as a powerful tool to explore couplings between brain structure and functional impairments in the human brain.
Collapse
Affiliation(s)
- Barbara Hollunder
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Jill L Ostrem
- Movement Disorders and Neuromodulation Centre, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
| | - Ilkem Aysu Sahin
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Nanditha Rajamani
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Simón Oxenford
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Konstantin Butenko
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Clemens Neudorfer
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Pablo Reinhardt
- Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Patricia Zvarova
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Mircea Polosan
- Université Grenoble Alpes, Grenoble, France
- Inserm, U1216, Grenoble Institut des Neurosciences, Grenoble, France
- Department of Psychiatry, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France
| | - Harith Akram
- Unit of Functional Neurosurgery, UCL Queen Square Institute of Neurology, London, UK
- Victor Horsley Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, UK
| | - Matteo Vissani
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- The BioRobotics Institute, Scuola Superiore Sant'Anna, Pisa, Italy
- Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy
| | - Chencheng Zhang
- Department of Neurosurgery, Rujin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Bomin Sun
- Department of Neurosurgery, Rujin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Pavel Navratil
- Department of Neurology, University Hospital Würzburg, Würzburg, Germany
| | - Martin M Reich
- Department of Neurology, University Hospital Würzburg, Würzburg, Germany
| | - Jens Volkmann
- Department of Neurology, University Hospital Würzburg, Würzburg, Germany
| | - Fang-Cheng Yeh
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Juan Carlos Baldermann
- Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
- Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Till A Dembek
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Veerle Visser-Vandewalle
- Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | | | | | - Pranav Nanda
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Carsten Finke
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany
- Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Andrea A Kühn
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany
- NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Darin D Dougherty
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - R Mark Richardson
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Hagai Bergman
- Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel
- Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, The Hebrew University, Hadassah Medical School, Jerusalem, Israel
- Department of Neurosurgery, Hadassah Medical Center, Jerusalem, Israel
| | - Mahlon R DeLong
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
| | - Alberto Mazzoni
- The BioRobotics Institute, Scuola Superiore Sant'Anna, Pisa, Italy
- Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy
| | - Luigi M Romito
- Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Himanshu Tyagi
- Unit of Functional Neurosurgery, UCL Queen Square Institute of Neurology, London, UK
- Department of Neuropsychiatry, The National Hospital for Neurology and Neurosurgery, London, UK
| | - Ludvic Zrinzo
- Unit of Functional Neurosurgery, UCL Queen Square Institute of Neurology, London, UK
- Victor Horsley Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, UK
| | - Eileen M Joyce
- Unit of Functional Neurosurgery, UCL Queen Square Institute of Neurology, London, UK
- Department of Neuropsychiatry, The National Hospital for Neurology and Neurosurgery, London, UK
| | - Stephan Chabardes
- Université Grenoble Alpes, Grenoble, France
- Inserm, U1216, Grenoble Institut des Neurosciences, Grenoble, France
- Department of Neurosurgery, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France
| | - Philip A Starr
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Ningfei Li
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
| | - Andreas Horn
- Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
| |
Collapse
|